Literature DB >> 9041711

Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells.

T A Hsu1, M J Betenbaugh.   

Abstract

Infection of Trichoplusia ni (BTI-TN5B1-4) insect cells with a baculovirus coding for immunoglobulin G resulted in significant intracellular insolubility of the immunoglobulin chains. In order to increase the immunoglobulin solubility, the chaperone BiP was coexpressed in the insect cells using a separate baculovirus vector. This heterologous BiP was observed to associate with immunoglobulin chains in vivo and enhance the level of soluble intracellular and secreted IgG obtained from T.ni. Pulse chase studies indicated that the heterologous BiP increased the level of soluble nascent immunoglobulin chains and assembly intermediates to suggest that BiP is acting as a true molecular chaperone. The effect of heterologous BiP became more significant with time post-infection as secreted IgG levels increased by 90% after 3.4 days of baculovirus infection. Even following the treatment of cells with tunicamycin, BiP coexpression still enhanced immunoglobulin solubility and secretion to indicate that BiP does not function specifically to retain unglycosylated proteins in the endoplasmic reticulum. Thus, coexpression of a molecular chaperone may be used to enhance cellular productivity and protein secretion provided that the chaperone is involved with post-translational processing and significant protein aggregation is observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041711     DOI: 10.1021/bp960088d

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  15 in total

1.  Improved antibody production in Chinese hamster ovary cells by ATF4 overexpression.

Authors:  Ahmad M Haredy; Akitoshi Nishizawa; Kohsuke Honda; Tomoshi Ohya; Hisao Ohtake; Takeshi Omasa
Journal:  Cytotechnology       Date:  2013-09-13       Impact factor: 2.058

2.  Introduction to animal cell culture technology-past, present and future.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2006-08-03       Impact factor: 2.058

Review 3.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

4.  Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system.

Authors:  V A Morais; J Serpa; A S Palma; T Costa; L Maranga; J Costa
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

5.  Molecular chaperone-assisted production of human alpha-1,4-N-acetylglucosaminyltransferase in silkworm larvae using recombinant BmNPV bacmids.

Authors:  Makoto Nakajima; Tatsuya Kato; Shin Kanamasa; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2009-05-06       Impact factor: 2.695

6.  The Rubella virus capsid is an anti-apoptotic protein that attenuates the pore-forming ability of Bax.

Authors:  Carolina S Ilkow; Ing Swie Goping; Tom C Hobman
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

7.  Engineering of chaperone systems and of the unfolded protein response.

Authors:  Saeed U Khan; Martin Schröder
Journal:  Cytotechnology       Date:  2008-08-15       Impact factor: 2.058

Review 8.  Engineering eukaryotic protein factories.

Authors:  Martin Schröder
Journal:  Biotechnol Lett       Date:  2007-09-21       Impact factor: 2.461

9.  Enhanced recombinant protein production and differential expression of molecular chaperones in sf-caspase-1-repressed stable cells after baculovirus infection.

Authors:  Yiu-Kay Lai; John T-A Hsu; Chih-Chieh Chu; Teng-Yuan Chang; Kao-Lu Pan; Chih-Chien Lin
Journal:  BMC Biotechnol       Date:  2012-11-07       Impact factor: 2.563

10.  Construction of new ligation-independent cloning vectors for the expression and purification of recombinant proteins in silkworms using BmNPV bacmid system.

Authors:  Tatsuya Kato; James R Thompson; Enoch Y Park
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.